BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 19, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
Feb. 4, 2004
View Archived Issues
Cyclacel's Fourth Round Gets $39M For Cell Cycle Inhibitors
LONDON - Cyclacel Ltd. raised £21.3 million (US$39 million) in an oversubscribed fourth round of private funding, bringing its total private equity raised to date to $123 million. (BioWorld International)
Read More
Acambis Moving R&D Core To U.S.,Cutting Work Force By 40
Read More
Predatory Bacterium Could Hold Key To Antibiotic Treasure Trove
Read More
With GLP-2 In Osteoporosis Focus, Sanos Raises $10M
Read More
PharmaMar Cutting Staff To Conserve Cash For Yondelis
Read More
ExonHit Raises Additional EUR8.3M; Now Has Cash To Last Into 2006
Read More
Another European Request For Lifting GMO Moratorium
Read More
Dissent With Partner Spurs Cutbacks At Micromet AG
Read More
Other News To Note
Read More